Cargando…

Exploring the Link between Cardiorenal and Metabolic Diseases

Detalles Bibliográficos
Autores principales:	D’Marco, Luis, Checa-Ros, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650723/ https://www.ncbi.nlm.nih.gov/pubmed/37957976 http://dx.doi.org/10.3390/healthcare11212831

Ejemplares similares

Pseudoxanthoma Elasticum and Cardiorenal Disease: A Case Report
por: D’Marco, Luis, et al.
Publicado: (2019)

Role of Omega-3 Fatty Acids as Non-Photic Zeitgebers and Circadian Clock Synchronizers
por: Checa-Ros, Ana, et al.
Publicado: (2022)

Cardiorenal Fat: A Cardiovascular Risk Factor With Implications in Chronic Kidney Disease
por: D'Marco, Luis, et al.
Publicado: (2021)

The Cardiorenal Syndrome
por: Rosner, Mitchell H., et al.
Publicado: (2011)

Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation
por: D’Marco, Luis, et al.
Publicado: (2022)

Cardiorenal Syndrome: Ebony and Ivory
por: Florens, Nans
Publicado: (2023)

Cardiovascular and Renal Links along the Cardiorenal Continuum
por: García-Donaire, José A., et al.
Publicado: (2011)

Hepcidin as a Biomarker of Cardiorenal Syndrome
por: Kim, Gheun-Ho
Publicado: (2019)

Is S100B Involved in Attention-Deficit/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and ω-3 PUFAs
por: Ouadih-Moran, Miriam, et al.
Publicado: (2023)

ROS, Klotho and mTOR in cardiorenal aging
por: Daneshgar, Nastaran, et al.
Publicado: (2020)

Cardiorenal metabolic biomarkers link early life stress to risk of non-communicable diseases and adverse mental health outcomes
por: Poplawski, Janet, et al.
Publicado: (2020)

Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial
por: Checa-Ros, Ana, et al.
Publicado: (2023)

Fifty Shades of Central Venous Pressure in the Cardiorenal Syndrome
por: Redant, Sebastien, et al.
Publicado: (2020)

New Advances in Cardiorenal Syndrome—Ready for Prime Time?
por: Pliquett, Rainer U.
Publicado: (2022)

The Effect of Aldosterone on Cardiorenal and Metabolic Systems
por: Otsuka, Hiromasa, et al.
Publicado: (2023)

Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
por: Shi, Shuqing, et al.
Publicado: (2022)

Changing the diabetes treatment paradigm from glucose control to cardiorenal protection
por: Ekanayake, Preethika, et al.
Publicado: (2021)

Cardiorenal protective effect of sodium–glucose cotransporter 2 inhibitors and mitochondrial function
por: Lee, Hong Kyu
Publicado: (2019)

DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
por: Handelsman, Yehuda, et al.
Publicado: (2022)

Cardiorenal syndrome
por: Ye, Wen Qing Wendy, et al.
Publicado: (2023)

Cardiorenal syndrome
por: Schetz, Miet
Publicado: (2009)

The Diabetic Cardiorenal Nexus
por: D’Elia, John A., et al.
Publicado: (2022)

Estimation of glomerular filtration rate in cardiorenal patients: a step forward
por: Quiroga, Borja, et al.
Publicado: (2023)

Cardiorenal Disease in COVID-19 Patients
por: Sifaat, Muhtasham, et al.
Publicado: (2022)

Cardiorenal Protection in Diabetic Kidney Disease
por: Lee, Jason F., et al.
Publicado: (2021)

SGLT2 Inhibitors and the Cardiorenal Continuum: A Paradigm Shift in the Treatment of Patients with T2D
por: Escalada, Javier
Publicado: (2022)

Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4
por: Amador-Martínez, Isabel, et al.
Publicado: (2023)

Wholegrain Consumption and Risk Factors for Cardiorenal Metabolic Diseases in Chile: A Cross-Sectional Analysis of 2016–2017 Health National Survey
por: Lanuza, Fabian, et al.
Publicado: (2020)

Role of the Nephrologist in Non-Kidney Solid Organ Transplant (NKSOT)
por: Viejo-Boyano, Iris, et al.
Publicado: (2023)

Cardiorenal Syndromes and Sepsis
por: Chelazzi, C., et al.
Publicado: (2011)

Biomarkers in Cardiorenal Syndromes
por: Fu, Shihui, et al.
Publicado: (2018)

Biomarkers in Cardiorenal Syndrome
por: Goffredo, Giovanni, et al.
Publicado: (2021)

Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
por: Verma, Subodh
Publicado: (2020)

Management of Cardiorenal Metabolic Syndrome in Diabetes Mellitus: A Phytotherapeutic Perspective
por: Song, Min Kyong, et al.
Publicado: (2014)

Exploring Better Links Between Clinics and Communities to Improve Population Health
por: Briss, Peter A.
Publicado: (2015)

Missing links exploring transitions
por: Nick, Peter
Publicado: (2023)

microRNAs Are Key Regulators in Chronic Lung Disease: Exploring the Vital Link between Disease Progression and Lung Cancer
por: Eapen, Mathew Suji, et al.
Publicado: (2019)

Cardiorenal syndrome and diabetes: an evil pairing
por: Méndez Fernández, Ana Belén, et al.
Publicado: (2023)

Exploring the Link between Helicobacter pylori Eradication and Metachronous Gastric Cancer Development
por: Yang, Hyo-Joon
Publicado: (2018)

The Cardiorenal Syndrome: Making the Connection
por: Viswanathan, Gautham, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ptkriv4e34lurf6nmoc33nk860